B3 · BRL
HAPV3
Hapvida Participacoes e Investimentos SA
- Day's range
- R$6.35 – R$6.76
- Day's volume
- R$58m
- 52-week range
- R$6.01 – R$36.53
Follow HAPV3 on Fuolio
See how HAPV3 weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountHAPV3 in numbers
- Market cap
- R$3.4bn
- P/E
- -19.31
- P/B
- 0.07
- Dividend yield (12m)
- 0.00%
- Net debt/EBITDA
- 2.32
HAPV3 price history
HAPV3 risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -78.68% | -87.95% | -96.14% |
| Volatility (annualised) | 75.01% | 56.88% | 60.21% |
| Largest drawdown | -79.35% | -90.32% | -96.60% |
| Positive months | 4/12 | 15/36 | 26/60 |
How much did investing in HAPV3 return?
R$1,000.00 invested on 01/10/2021 would be worth R$38.55 today.
- Value today in HAPV3
- R$38.55
- Return over the period
- -96.14%
- Return per year
- -47.88%
- In the Ibovespa
- R$1,777.43
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
HAPV3 fundamentals
Valuation
- P/E-19.31
- P/B0.07
- EV/EBITDA3.87
- EV/EBIT5.42
- EV/Revenue0.26
- P/EBIT2.17
- P/S0.11
- P/OCF2.22
- P/FCF0.89
- Earnings yield18.43%
- PEG ratio-0.29
- Earnings per share-R$0.35
- Book value per shareR$95.62
Debt
- Net debtR$5bn
- Net debt/EBITDA2.32
- Net debt/Equity0.10
- Debt/Equity0.27
- Current ratio1.83
- Quick ratio1.77
- Cash ratio1.32
Efficiency
- Gross margin12.85%
- EBITDA margin6.80%
- Operating margin4.85%
- Net margin-0.54%
- Asset turnover0.44
Profitability
- ROE-0.36%
- ROA-0.24%
- ROIC2.91%
- Payout—
Growth
- Revenue CAGR (5 years)28.41%
- Earnings CAGR (5 years)—
- Revenue growth (year)9.21%
- Earnings growth (year)78.17%
- Revenue growth (quarter)8.03%
- Earnings growth (quarter)63.72%
What is HAPV3's fair price?
Two classic value formulas, with today's numbers. The current price is R$6.67.
- Graham's fair price
- —
- Does not apply to HAPV3: the formula needs positive earnings and book value.
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- R$0.71
- 89.42% below the price
R$0.04 (5-year average) ÷ 6%
Décio Bazin only bought shares yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years divided by 6%.
Graham ignores growth and debt; Bazin assumes past distributions will repeat. They are reference points for comparison, not a buy recommendation.
HAPV3 indicators by year
Multiples at each year's closing price; margins and returns from that year's accounts.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | -52.23 | -25.89 | -44.27 | -46.78 | 148.93 | 72.46 | 55.87 | 26.62 |
| P/B | 0.15 | 0.35 | 0.68 | 0.74 | 7.01 | 7.25 | 6.54 | 5.81 |
| EV/EBITDA | 5.33 | 13.92 | 23.00 | 21.37 | 54.00 | 27.91 | 39.07 | 21.99 |
| Dividend yield | 0.00% | 0.00% | 0.00% | 0.01% | 0.13% | 0.29% | 0.24% | — |
| Earnings per share | -R$0.28 | -R$0.09 | -R$0.10 | -R$0.11 | R$0.07 | R$0.21 | R$1.14 | R$1.17 |
| Book value per share | R$96.00 | R$6.46 | R$6.53 | R$6.82 | R$1.48 | R$2.11 | R$9.77 | R$5.37 |
| ROE | -0.29% | -1.33% | -1.54% | -1.59% | 4.71% | 10.00% | 11.70% | 21.84% |
| ROIC | 1.66% | 1.41% | 2.18% | -0.15% | 3.85% | 11.82% | 9.78% | 24.22% |
| Gross margin | 11.79% | 11.42% | 10.95% | 23.81% | 31.02% | 39.11% | 39.65% | 39.80% |
| EBITDA margin | 7.37% | 5.17% | 5.96% | 8.55% | 14.55% | 23.61% | 21.89% | 19.95% |
| Net margin | -0.45% | -2.25% | -2.73% | -3.27% | 5.04% | 9.16% | 15.08% | 17.21% |
| Net debt/EBITDA | 2.15 | 2.66 | 2.73 | 3.50 | 2.45 | -0.20 | 0.57 | -0.97 |
HAPV3 financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | R$31.6bn | R$28.9bn | R$27.8bn | R$23.7bn | R$9.9bn | R$8.6bn |
| Cost of sales | -R$27.9bn | -R$25.6bn | -R$24.7bn | -R$18.1bn | -R$6.8bn | -R$5.2bn |
| Gross profit | R$3.7bn | R$3.3bn | R$3bn | R$5.7bn | R$3.1bn | R$3.3bn |
| EBITDA | R$2.3bn | R$1.5bn | R$1.7bn | R$2bn | R$1.4bn | R$2bn |
| EBIT | R$1.5bn | R$741m | R$1.2bn | -R$155.9m | R$543.3m | R$1.3bn |
| Net finance result | -R$1.7bn | -R$1.2bn | -R$1.9bn | -R$1.3bn | -R$50.4m | -R$134.5m |
| Profit before tax | -R$233.8m | -R$467.3m | -R$701.2m | -R$1.4bn | R$492.9m | R$1.1bn |
| Income tax | R$91.7m | -R$188.1m | -R$56.8m | R$672m | R$7.5m | -R$347.4m |
| Net income | -R$141.7m | -R$649.3m | -R$757.9m | -R$775.8m | R$497.8m | R$783.5m |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
HAPV3 against its sector
The same indicators for the company's other shares and the sector's largest stocks.
| Stock | P/E | P/B | Dividend yield (12m) | ROE | Market cap |
|---|---|---|---|---|---|
| HAPV3Hapvida Participacoes E Investimentos | -19.31 | 0.07 | 0.00% | -0.36% | R$3.4bn |
| RDOR3REDE DOR SÃO LUIZ S.A. | 17.79 | 4.14 | 10.99% | 23.26% | R$85.8bn |
| SAUD3SAUD3 | 37.04 | 2.09 | 3.05% | 5.63% | R$39bn |
| FLRY3FLEURY S.A. | 17.71 | 2.30 | 5.70% | 13.00% | R$12.5bn |
| DASA3DIAGNOSTICOS DA AMERICA S.A. | -5.59 | 0.73 | 0.00% | -13.09% | R$5bn |
| MATD3HOSPITAL MATER DEI S/A | 11.90 | 1.13 | 2.97% | 9.50% | R$1.7bn |
Does HAPV3 pay dividends?
Dividend yield per year
- 0.24%2019
- 0.29%2020
- 0.13%2021
- 0.01%2022
- 0.00%2023
- 0.00%2024
- 0.00%2025
- 0.00%2026
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Interest on equity | 27/12/2021 | 21/01/2022 | R$0.01 |
| Interest on equity | 27/09/2021 | 22/10/2021 | R$0.01 |
| Interest on equity | 06/07/2021 | 30/07/2021 | R$0.02 |
| Dividend | 05/05/2021 | 17/05/2021 | R$0.00 |
| Interest on equity | 07/01/2021 | 30/04/2021 | R$0.03 |
| Interest on equity | 10/09/2020 | 30/04/2021 | R$0.15 |
| Dividend | 28/04/2020 | 30/12/2020 | R$0.02 |
| Dividend | 24/03/2020 | 25/08/2020 | R$0.17 |
| Dividend | 28/04/2020 | 24/07/2020 | R$0.01 |
| Interest on equity | 27/12/2019 | 24/07/2020 | R$0.08 |
| Interest on equity | 28/06/2019 | 24/07/2020 | R$0.08 |
| Interest on equity | 03/01/2020 | 30/04/2020 | R$0.16 |
See all 17 distributions
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Interest on equity | 02/07/2019 | 30/04/2020 | R$0.16 |
| Dividend | 22/04/2019 | 30/04/2019 | R$0.12 |
| Interest on equity | 14/12/2018 | 30/04/2019 | R$0.18 |
| Dividend | 27/03/2019 | 09/04/2019 | R$0.15 |
| Dividend | 10/02/2022 | — | R$1.61 |
| Event | Last day to own | Ratio |
|---|---|---|
| Share consolidation | 05/06/2025 | 1 for 15 |
| Split | 24/11/2020 | 5 for 1 |
About Hapvida Participacoes E Investimentos
- Sector
- Saúde
- Segment
- Serviços Médicos Hospitalares
- Listing segment
- Novo Mercado
- Tag along
- 100.00%
- Free float
- 54.84%
- Shares issued
- 502.63m ordinary
- Average daily trading
- R$61.8m
- Ibovespa weight
- 0.07%
- Listed since
- 25/04/2018
- CNPJ
- 05.197.443/0001-38
A Hapvida Participações e Investimentos S.A., listada na B3 sob o ticker HAPV3, tem origem em 1979 e atua no setor de saúde suplementar no Brasil. A companhia opera modelo verticalizado de assistência médica e odontológica, com rede própria e credenciada. Seus negócios incluem comercialização e gestão de planos de saúde e odontológicos, hospitais, clínicas, pronto atendimento e serviços diagnósticos. Após integração com a NotreDame Intermédica, o grupo ampliou escala nacional e base de beneficiários em diferentes perfis de cobertura. No ambiente competitivo, a empresa concorre com operadoras de planos e grupos integrados de saúde, com foco em custo assistencial, sinistralidade e eficiência de rede. O setor é influenciado por dinâmica regulatória, inflação médica e capacidade de gestão de utilização dos serviços. A atuação é nacional, com presença relevante em diversas regiões e rede assistencial extensa. Em escala operacional, o grupo informa mais de 60 mil empregados e milhões de beneficiários, com estrutura integrada entre operação de planos e prestação de serviços médico-hospitalares.
Investor website| Shareholder | Ordinary | Preferred | Total |
|---|---|---|---|
| PPAR Pinheiro Participações S.A.Controlling | 34.06% | 0.00% | 34.06% |
| ANA CHRISTINA FONTOURA KOREN DE LIMAControlling | 1.78% | 0.00% | 1.78% |
| PEDRO E EUGENIA EMPRESA DE PARTICIPACOES LTDAControlling | 1.74% | 0.00% | 1.74% |
| JORGE FONTOURA PINHEIRO KOREN DE LIMAControlling | 1.32% | 0.00% | 1.32% |
| DAVID MELO PINHEIRO KOREN DE LIMA | 0.15% | 0.00% | 0.15% |
| CANDIDO PINHEIRO KOREN DE LIMA NETO | 0.15% | 0.00% | 0.15% |
| RAQUEL MELO PINHEIRO KOREN DE LIMA | 0.15% | 0.00% | 0.15% |
| SARAH MELO PINHEIRO KOREN DE LIMA | 0.15% | 0.00% | 0.15% |
| CANDIDO PINHEIRO KOREN DE LIMAControlling | 0.08% | 0.00% | 0.08% |
| CANDIDO PINHEIRO KOREN DE LIMA JUNIORControlling | 0.07% | 0.00% | 0.07% |
| Outros | 54.88% | 0.00% | 54.88% |
| Ações Tesouraria | 5.48% | 0.00% | 5.48% |
Questions about HAPV3
How much is HAPV3 today?
HAPV3 is at R$6.67 (6.21% on the day), last traded on 30/09/2026.
How much did HAPV3 pay in dividends in 2025?
HAPV3 paid R$0.00 per share in 2025, a dividend yield of 0.00%.
What are the P/E and P/B of HAPV3?
HAPV3 trades at a P/E of -19.31 and a P/B of 0.07.
How much did HAPV3 return in 12 months?
HAPV3 returned -78.68% in 12 months, with annualised volatility of 75.01% and a largest drawdown of -79.35%.
What sector is HAPV3 in?
Hapvida Participacoes E Investimentos is in the Saúde sector, Serviços Médicos Hospitalares segment.